| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10461500 | Neuroscience & Biobehavioral Reviews | 2013 | 11 Pages |
Abstract
⺠Structural MRI has the potential to assess progression in clinical trials. ⺠The most promising biomarkers in HD are striatal and white matter atrophy. ⺠Consideration of image acquisition, processing and statistical design is essential. ⺠Appropriate reporting of study design is vital to allow evaluation of the literature.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Nellie Georgiou-Karistianis, Rachael Scahill, Sarah J. Tabrizi, Ferdinando Squitieri, Elizabeth Aylward,